Commentary to Impact of Sacubitril-Valsartan Treatment on Diastolic Function in Patients with Heart Failure and Reduced Ejection Fraction

被引：0
|
作者：
Agata Buonacera
Benedetta Stancanelli
Lorenzo Malatino
机构：
[1] University of Catania,Academic Unit of Internal Medicine and Hypertension Centre, Department of Clinical and Experimental Medicine
[2] c/o Cannizzaro Hospital,undefined
来源：
High Blood Pressure & Cardiovascular Prevention | 2021年 / 28卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：331 / 332
页数：1
相关论文
共 50 条
  • [21] Dapagliflozin versus sacubitril-valsartan for heart failure with mildly reduced or preserved ejection fraction
    Arbel, Ronen
    Azab, Abed N.
    Oberoi, Mansi
    Aboalhasan, Enis
    Star, Artyom
    Elhaj, Khaled
    Khalil, Fouad
    Alnsasra, Hilmi
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [22] Influence of sacubitril/valsartan on diastolic parameters in patients with chronic heart failure with reduced ejection fraction
    Uzokov, J.
    Mukhamedova, M. G.
    Narzullaeva, D. S.
    Nosirova, G. A.
    Orziev, D. Z.
    Majidov, I
    EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING, 2022, 21 (SUPP_1) : I19 - I19
  • [23] DAPAGLIFLOZIN VERSUS SACUBITRIL-VALSARTAN FOR HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION
    Arbel, Ronen
    Oberoi, Mansi
    Alnsasra, Hilmi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 628 - 628
  • [24] Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction
    Jackson, Alice M.
    Jhund, Pardeep S.
    Anand, Inder S.
    Duengen, Hans-Dirk
    Lam, Carolyn S. P.
    Lefkowitz, Marty P.
    Linssen, Gerard
    Lund, Lars H.
    Maggioni, Aldo P.
    Pfeffer, Marc A.
    Rouleau, Jean L.
    Saraiva, Jose F. K.
    Senni, Michele
    Vardeny, Orly
    Wijkman, Magnus O.
    Yilmaz, Mehmet B.
    Saito, Yoshihiko
    Zile, Michael R.
    Solomon, Scott D.
    McMurray, John J., V
    EUROPEAN HEART JOURNAL, 2021, 42 (36) : 3741 - +
  • [25] Impact of sacubitril/valsartan treatment on depression and anxiety in heart failure with reduced ejection fraction
    Dereli, Seckin
    Kilincel, Oguzhan
    Cerik, Idris Bugra
    Kaya, Ahmet
    ACTA CARDIOLOGICA, 2020, 75 (08) : 774 - 782
  • [26] Sacubitril-valsartan modifies the indication of cardiac implantable devices in patients with heart failure and reduced ejection fraction
    Belarte-Tornero, Laia Carla
    Mojon, Diana
    Sole-Gonzalez, Eduard
    Ruiz-Bustillo, Sonia
    Valdivielso-More, Sandra
    Farre, Nuria
    REVISTA ESPANOLA DE CARDIOLOGIA, 2021, 74 (12): : 1118 - +
  • [27] Cost-Effectiveness of Sacubitril-Valsartan in Patients Who Have Heart Failure With Reduced Ejection Fraction
    King, Jordan
    Bress, Adam
    Bellows, Brandon
    ANNALS OF INTERNAL MEDICINE, 2017, 166 (08) : 606 - 607
  • [28] Impact of Sacubitril/Valsartan on Lipid Parameters in Patients with Heart Failure with Reduced Ejection Fraction
    Hasan Ali Barman
    Selim Tanyolaç
    Omer Dogan
    Erdem Bal
    Adem Atıcı
    Serhan Özyıldırım
    Zerrin Yiğit
    Clinical Drug Investigation, 2022, 42 : 533 - 540
  • [29] Impact of Sacubitril/Valsartan on Lipid Parameters in Patients with Heart Failure with Reduced Ejection Fraction
    Barman, Hasan Ali
    Tanyolac, Selim
    Dogan, Omer
    Bal, Erdem
    Atici, Adem
    Ozyildirim, Serhan
    Yigit, Zerrin
    CLINICAL DRUG INVESTIGATION, 2022, 42 (06) : 533 - 540
  • [30] Sacubitril-Valsartan, a New Opportunity for Heart Failure with Recovered Ejection Fraction?
    Agra-Bermejo, Rosa
    Alvarez Rodriguez, Leyre
    Gonzalez-Juanatey, Jose R.
    CARDIOLOGY, 2020, 145 (05) : 283 - 284
12345